(J Cardiac Fail 2012;18:433-438)”
“The macroscopic phase sep

(J Cardiac Fail 2012;18:433-438)”
“The macroscopic phase separation of undercooled liquid Fe50Sn50 immiscible alloy was investigated by both drop tube experiment and the modified Model H. Core-shell structures with two, three, and five layers were formed during experiment. The concentric shells comprised of Fe-rich phase and Sn-rich phase distribute periodically in the solidified droplet, and the Sn-rich phase is always located at the sample surface owing to its smaller surface tension. The

simulated results of modified Model H reproduce core-shell structures with the same layers, which justifies the prediction of this model. If the fluidity parameter C-f and solute concentration phi AZD1390 satisfy the physical conditions of both C-f < 1 and 0 <phi < 0.45 or C-f >= 1, the phase separation morphology exhibits the double-layer core-shell structure, whereas the multilayer core-shell structure is expected to form under the conditions of both C-f < 1 and 0.45 <phi < 0.5. The forming ability of core-shell structure for various immiscible alloys can be predicted Epigenetic pathway inhibitor accordingly.”
“Magnesium trifluoromethanesulfonate (Mg (CF3SO3)(2))-based polymer electrolytes (PEs) have been prepared with polyvinylidene

fluoride (PVdF) as a host matrix. Tetraglyme and tetrabutyl ammonium chloride (TBACl) were used as plasticizer and filler, respectively, in the matrix by solution-casting technique. The electrolyte containing 5 wt % TBACl exhibits the conductivity of 0.442 mS cm(-1) at ambient temperature. X-ray diffraction study reveals the amorphous nature of the PE. Linear sweep voltammetry was also performed to evaluate the decomposition potential of the electrolyte. The morphological features were analyzed by scanning

electron microscope. The activation energy has also been calculated, which corroborates the ionic conductivity results. (c) 2009 Wiley Periodicals, Inc. J Appl Polym Sci 112: 3024-3029, 2009″
“Background: Hyperglycemia predicts death LDN-193189 in cardiovascular disease, but intensive glucose-lowering strategies increase mortality rates in diabetes. The present analysis investigated the prognostic value of postadmission blood glucose (BG) concentration on clinical outcomes in high-risk patients with heart failure after acute myocardial infarction.

Methods and Results: A total of 6,496 patients from the Eplerenone Post Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) were categorized into 4 groups by plasma glucose concentration: <= 4.5 mmol/L (hypoglycemia), 4.5-5.5 mmol/L (normoglycemia), 5.5-8.3 mmol/L (elevated glucose level), and >8.3 mmol/L (severe hyperglycemia). We evaluated the time to all-cause death (primary end point) and time to cardiovascular death or hospitalization (secondary end point). Hypo- and severe hyperglycemia were prevalent in 509 (8%) and 1,588 (24%) patients, respectively.

Comments are closed.